HighPoint Advisor Group LLC bought a new position in Rite Aid Co. (NYSE:RAD) during the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 79,102 shares of the company’s stock, valued at approximately $112,000.

Other hedge funds and other institutional investors have also recently modified their holdings of the company. HRT Financial LLC purchased a new position in shares of Rite Aid in the second quarter worth $105,000. GSA Capital Partners LLP purchased a new position in Rite Aid during the 2nd quarter valued at $105,000. Bay Colony Advisory Group Inc d b a Bay Colony Advisors purchased a new position in Rite Aid during the 2nd quarter valued at $108,000. Destination Wealth Management increased its position in Rite Aid by 5,513.1% during the 2nd quarter. Destination Wealth Management now owns 65,000 shares of the company’s stock valued at $112,000 after purchasing an additional 63,842 shares during the period. Finally, NEXT Financial Group Inc increased its position in Rite Aid by 62.5% during the 1st quarter. NEXT Financial Group Inc now owns 73,850 shares of the company’s stock valued at $124,000 after purchasing an additional 28,400 shares during the period. 55.59% of the stock is currently owned by institutional investors.

A number of research analysts have issued reports on RAD shares. Cowen reissued a “buy” rating and set a $2.35 price objective on shares of Rite Aid in a research report on Thursday, June 28th. Zacks Investment Research downgraded shares of Rite Aid from a “buy” rating to a “hold” rating in a research report on Tuesday, July 10th. Mizuho reissued a “hold” rating and set a $2.00 price objective on shares of Rite Aid in a research report on Thursday, August 9th. TheStreet downgraded shares of Rite Aid from a “c-” rating to a “d” rating in a research report on Wednesday, August 8th. Finally, Goldman Sachs Group started coverage on shares of Rite Aid in a research report on Thursday, September 6th. They set a “sell” rating and a $1.00 price objective on the stock. Two analysts have rated the stock with a sell rating, seven have issued a hold rating and one has given a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average target price of $2.37.

Shares of Rite Aid stock opened at $1.33 on Wednesday. The company has a current ratio of 1.49, a quick ratio of 0.85 and a debt-to-equity ratio of 1.75. The firm has a market cap of $1.38 billion, a price-to-earnings ratio of -66.50 and a beta of 1.83. Rite Aid Co. has a 12-month low of $1.23 and a 12-month high of $2.64.

Rite Aid (NYSE:RAD) last announced its earnings results on Wednesday, June 27th. The company reported ($0.01) EPS for the quarter, meeting the Zacks’ consensus estimate of ($0.01). Rite Aid had a net margin of 5.18% and a negative return on equity of 2.88%. The firm had revenue of $5.39 billion for the quarter, compared to analysts’ expectations of $5.32 billion. During the same quarter in the previous year, the business posted ($0.05) EPS. The company’s quarterly revenue was down .9% on a year-over-year basis. analysts forecast that Rite Aid Co. will post -0.02 earnings per share for the current year.

Rite Aid Company Profile

Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. It operates through two segments, Retail Pharmacy and Pharmacy Services. The Retail Pharmacy segment sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other every day and convenience products.

Featured Article: Asset Allocation, Balancing Your Investments

Want to see what other hedge funds are holding RAD? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Rite Aid Co. (NYSE:RAD).

Institutional Ownership by Quarter for Rite Aid (NYSE:RAD)

Receive News & Ratings for Rite Aid Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rite Aid and related companies with MarketBeat.com's FREE daily email newsletter.